Clinical Trial Highlights

• 4-Year Follow-up Shows No Increased Mortality with Drug-Eluting Stents Compared to Bare Metal Stents in over 60,000 Patients
• 3-Year Clinical Data Continue to Show Superiority of Sirolimus-Eluting versus Bare Metal Stents in STEMI Patients
• Enoxaparin Continues to Show Clinical Benefit Vs Unfractionated Heparin for STEMI
• No Benefit Shown for Facilitated PCI
• Immediate Angioplasty after Thrombolytic Therapy Can save Lives and Reduce Recurrent Heart Attacks in AMI Patients
• Study Supports Anti-Arrhythmic Effects of Ranolazine in Patients with Acute Coronary Syndrome
• Subgroup Analysis of BENEFiT Trial to Evaluate Effect of Bosentan for Patients with CTEPH
• Angiographic and Clinical Outcomes after PCI for Stent-Thrombosis
• The Use of Drug-Eluting Stents in Patients with ST-Elevation Myocardial Infarction Increases Mortality Compared to Bare Metal Stenting at 2-Years
• Lowering Blood Pressure in Patients with Type 2 Diabetes Significantly Reduces the Risk of Death from Diabetic Complications Even in Patients with Normal Blood Pressure